Jennifer Jiang

Jennifer Jiang, M.D., is a Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Florida. She specializes in hematopathology and molecular diagnostics, with expertise in lymphoma and myeloid neoplasms. Dr. Jiang completed her MD at Shanghai First Medical University and holds fellowships from the National Institutes of Health and University of Texas M.D. Anderson Cancer Center. Her research focuses on advancing diagnostic techniques and understanding the molecular basis of hematologic malignancies.

Key professional roles include leadership in diversity and inclusion initiatives at the International Clinical Cytometry Society and Mayo Clinic Florida. She has received multiple awards, including the DLMP Research Award (2025) and Anatomic Pathology Academic Achievement Award (2022). Her work spans over 100 peer-reviewed publications, emphasizing molecular profiling of lymphomas and optimizing clinical diagnostic practices.

Dr. Jiang serves on committees for organizations like the College of American Pathologists and American Society of Hematology. Her research contributions include studies on treatment outcomes for rare lymphomas, cost-effectiveness analyses of targeted therapies, and genomic insights into malignant histiocytosis.

Her laboratories and teams focus on translating molecular findings into clinical care, with a particular interest in CNS lymphoma and rare hematologic disorders. She actively participates in collaborative research networks, including the Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group.